Aims: To determine if cardiac enzymes measured at necropsy could be used to predict early myocardial infarction. Methods: Cardiac enzyme activities were measured in body fluids at necropsy. Coroners' necropsies were grouped by gross and microscopic findings into cases of definite myocardial infarction, cases with occlusive coronary artery atheroma but no identifiable myocardial infarction, and non-cardiac cases. Pericardial fluid, peripheral venous blood, and blood from the right atrium were collected. Total creatine phosphokinase, creatine phosphokinase isoenzymes, aspartate aminotransferase and hydroxybutarate dehydrogenase activities were measured and the results analysed by logistic regression. Results: The values of creatine phosphokinase and its isoenzymes were raised in those who had died of cardiac disease and were most discriminatory. Cases of early myocardial infarction without evidence of infarction on routine histological examination could be identified from enzyme activities. Conclusions: Measurement of cardiac enzymes in blood and pericardial fluid at 
gross and microscopic findings into cases of definite myocardial infarction, cases with occlusive coronary artery atheroma but no identifiable myocardial infarction, and non-cardiac cases. Pericardial fluid, peripheral venous blood, and blood from the right atrium were collected. Total creatine phosphokinase, creatine phosphokinase isoenzymes, aspartate aminotransferase and hydroxybutarate dehydrogenase activities were measured and the results analysed by logistic regression. Results: The values of creatine phosphokinase and its isoenzymes were raised in those who had died of cardiac disease and were most discriminatory. Cases of early myocardial infarction without evidence of infarction on routine histological examination could be identified from enzyme activities. Conclusions: Measurement of cardiac enzymes in blood and pericardial fluid at Our study has shown that death caused by early myocardial infarction can be predicted from cardiac enzyme activities at necropsy. Most non-cardiac deaths were correctly predicted (24 out of26) using the model in table 5. Five of the 13 cases in which there was histological evidence of infarction were predicted as cardiac deaths using this model. The fact that eight cases were not is not entirely surprising as the rise in enzymes may have occurred a few days before death and then returned to normal. In the cases of possible myocardial infarction 10 cases were classified as infarction, based on the enzyme activities. In these cases the rise in enzymes suggests that infarction was occurring but that death happened before histological evidence of infarction appeared. In the other 17 cases there was no histological or biochemical evidence of infarction. This is not surprising. In many of these cases there was probably a cardiac arrhythmia and very rapid death without any infarction. Very early infarction, with no rise in enzymes, or an insignificant rise, however, cannot be excluded.
The results of this study show that early myocardial infarction can be identified at necropsy using cardiac enzyme measurement of body fluids. The accuracy is increased if blood from the right atrium and peripheral venous blood is used in addition to pericardial fluid. If the post mortem examination interval is included in the analysis the accuracy is increased still further. The failure to identify a rise in enzymes in all cases of the definite infarction group does not, of course, present any practical problem, as infarction will be identified by gross or routine histological examination. Although not all cases of early myocardial infarction can be predicted using our model, any additional information when only occlusive coronary artery atheroma is present may be useful in controversial cases.
We recommend, therefore, in cases 
